Cibc World Markets Corp Takes $39,000 Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Cibc World Markets Corp bought a new position in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 17,683 shares of the biopharmaceutical company’s stock, valued at approximately $39,000. Other hedge funds and other institutional investors have also […]
Cibc World Markets Corp bought a new position in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 17,683 shares of the biopharmaceutical company’s stock, valued at approximately $39,000. Other hedge funds and other institutional investors have also […]
